Metabolic
Dulaglutide
Trulicity
- Molecular format
- GLP-1 analog–Fc fusion protein
GLP-1 analog–Fc fusion protein
Research contextDefined therapeutic evidence
Read the linked studies for their methods and limitations.
A long-acting GLP-1 receptor agonist built as an Fc fusion protein, with large randomized cardiovascular-outcome research in type 2 diabetes.
- Family
- GLP-1 fusion protein
- Research frame
- GLP-1 receptor
- Molecular format
- GLP-1 analog–Fc fusion protein
Read the evidence
REWIND studied clinical outcomes in a defined diabetes population. It is distinct from a short biomarker or receptor-activation experiment.
Resolve the identity
The complete molecule includes linked GLP-1 analog and Fc regions. A simple short-peptide residue count would misrepresent its structure.